Skip to content

Author

P. Meisner

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Efficacy and safety of rozanolixizumab in severe fibromyalgia: a phase 2A randomised, double-blind, placebo-controlled, multicentre trial.

BACKGROUND Fibromyalgia is a chronic disorder characterised by widespread pain, fatigue, sleep disturbances, and cognitive dysfunction. Evidence suggests pathogenic IgG autoantibodies might contribute to severe symptoms. Rozanolixizumab reduces IgG concentration by targeting the neonatal Fc receptor. This study evaluat...

Andreas Goebel, P. Meisner, Gustaf Rydevik et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.